Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Jules Bordet Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Institute of Oncology Ljubljana
West Virginia University
Institute of Oncology Ljubljana
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Florida
Institute of Oncology Ljubljana
University of Pittsburgh
Institute of Oncology Ljubljana
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Jonsson Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University of Utah
Wake Forest University Health Sciences
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National University Hospital, Singapore
Universitaire Ziekenhuizen KU Leuven
Massachusetts General Hospital
OHSU Knight Cancer Institute
Hospices Civils de Lyon
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Melanoma Institute Australia
Rutgers, The State University of New Jersey
Emory University
University of Oklahoma
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Centre Hospitalier Universitaire de Nīmes
H. Lee Moffitt Cancer Center and Research Institute
University of Utah
University of Utah
Bispebjerg Hospital
Dana-Farber Cancer Institute
British Columbia Cancer Agency
Saglik Bilimleri Universitesi